Cargando…
Codivir suppresses SARS-Cov-2 viral replication and stabilizes clinical outcome: In vitro and Phase I clinical trial results
BACKGROUND: Treatment of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) remains a significant challenge in the face of increased worldwide morbidity and mortality. The acute illness caused by SARS-CoV-2 is initiated by a viral phase, followed by an inflammatory phase. Numerous...
Autores principales: | Kolben, Yotam, Finkelshtein, Eynat, Naftali, Esmira, Kenig, Ariel, Kessler, Asa, Cardoso, Florentino, Lisovoder, Nadya, Schwartz, Asaf, Elbirt, Daniel, Maayan, Shlomo, Ilan, Yaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Applied Systems srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348448/ https://www.ncbi.nlm.nih.gov/pubmed/37457644 http://dx.doi.org/10.15190/d.2022.17 |
Ejemplares similares
-
Serum Levels of Adropin Improve the Predictability of MELD and Child-Pugh Score in Cirrhosis: Results of Proof-of-Concept Clinical Trial
por: Kolben, Yotam, et al.
Publicado: (2023) -
Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm
por: Kenig, Ariel, et al.
Publicado: (2021) -
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells
por: Shapira, Shiran, et al.
Publicado: (2021) -
Targeting SARS-CoV-2 receptors as a means for reducing infectivity and
improving antiviral and immune response: an algorithm-based method for overcoming
resistance to antiviral agents
por: Gelman, Ram, et al.
Publicado: (2020) -
A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment
por: Kenig, Ariel, et al.
Publicado: (2019)